NEW YORK (GenomeWeb) – Investment bank Mizuho Securities has upgraded shares of Fluidigm from Neutral to Buy citing improved end markets and the expected effects from the firm's recent acquisition of DVS Sciences.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: CRISPR-based barcodes to trace cell lineages, and more.
The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.
French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.
In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.